Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

McGill University

$25,000.00

Hyperbranched Dendritic Polyglycerols for Biocompatible Coatings

FY 2024-25

Summary
Research on neurological diseases often entails the study of neural cells (neurons) in vitro where long term cell growth requires special coatings on the plastic or glass surfaces. Canada is a global leader in the development of brain/machine interfaces for neurorehabilitation and new treatments for neurological disorders. Biocompatibility, whether for neural implants or neural cell culture, remains a major problem. A special class of branched rather than linear polymers known as hyperbranched polyglycerol amine dendrimers (dPGA) have been found to be exceptionally biocompatible when used as coatings for neural cell culture. However why these dendritic polymers work so well is not understood at the molecular level. We will collaborate with Rainer Haag at Freie University Berlin, who originally developed these polymers for biomedical applications, to synthesize and characterize a series of dPGA polymers of different sizes and amine groups to identify the key molecular properties for biocompatibility. Improvement in neural cell culture is critical for the development of new treatments for neurodegenerative diseases such as Parkinson, multiple sclerosis and Alzheimer's disease that effect the lives of millions of Canadians. The results will also guide the development of new and improved biocompatible coatings for biomedical applications such as anti-fouling coatings for medical implants, biosensors, and surgical equipment which can have a large impact on the effectiveness of existing medical treatments.
Program
Alliance Grants
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
597607-2024
Name nom
Reven, Linda L
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
3402
Research subject group en
Physical chemistry
Research subject group fr
Chimie physique
Research subject en
Surface and interfacial chemistry
Research subject fr
Chimie des surfaces et des interfaces
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Hyperbranched Dendritic Polyglycerols for Biocompatible Coatings
Keywords
afm; colloids; dendritic polyglycerols; ellipsometry; multilayer films; neural cell culture; nmr spectroscopy; polyelectrolytes
Application summary
Research on neurological diseases often entails the study of neural cells (neurons) in vitro where long term cell growth requires special coatings on the plastic or glass surfaces. Canada is a global leader in the development of brain/machine interfaces for neurorehabilitation and new treatments for neurological disorders. Biocompatibility, whether for neural implants or neural cell culture, remains a major problem. A special class of branched rather than linear polymers known as hyperbranched polyglycerol amine dendrimers (dPGA) have been found to be exceptionally biocompatible when used as coatings for neural cell culture. However why these dendritic polymers work so well is not understood at the molecular level. We will collaborate with Rainer Haag at Freie University Berlin, who originally developed these polymers for biomedical applications, to synthesize and characterize a series of dPGA polymers of different sizes and amine groups to identify the key molecular properties for biocompatibility. Improvement in neural cell culture is critical for the development of new treatments for neurodegenerative diseases such as Parkinson, multiple sclerosis and Alzheimer's disease that effect the lives of millions of Canadians. The results will also guide the development of new and improved biocompatible coatings for biomedical applications such as anti-fouling coatings for medical implants, biosensors, and surgical equipment which can have a large impact on the effectiveness of existing medical treatments.